Biocon Biologics to provide cancer biosimilars to 30 countries in Africa, Asia

Biocon Biologics said it aims to deliver substantial savings to healthcare systems by enhancing access and availability of these high-quality and affordable biosimilar cancer therapies in 25 countries in Africa and five countries in Asia, which are currently covered under CAP.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news